Table 1 Study Population Characteristics
Patient No. | MHC Class I | Before HAART Intensification | Before First Treatment Interruption (TI) | ||||
|---|---|---|---|---|---|---|---|
A | B | C | CD4 Cell Count (cells/mm3) | CD4 Cell % | CD4 Cell Count (cells/mm3) | CD4 Cell % | |
14001 | A2/A26 | B18/B39 | Cw7/Cw12 | 990 | 30 | 1120 | 33 |
14002 | A2/A1 | B60/B51 | Cw3/Cw14 | 330 | 25 | 280 | 25 |
14003 | A1/A3 | B7/B8 | Cw7/- | 650 | 25 | 590 | 27 |
14004 | A2/A3 | B38/B44 | Cw5/Cw12 | 400 | 19 | 370 | 22 |
14005 | A3/A69 | B35/B44 | Cw12/Cw7 | 230 | 21 | 510 | 27 |
14006 | A1/- | B8/B57 | Cw6/Cw7 | 440 | 23 | 410 | 24 |
14007 | A36/A68 | B7/B53 | Cw4/Cw7 | 370 | 16 | 320 | 17 |
14008 | A1/A68 | B8/B60 | Cw3/Cw7 | 350 | 14 | 720 | 19 |
14009 | A3/A29 | B35/B44 | Cw4/Cw16 | 710 | 37 | 800 | 38 |
14010 | A2/A66 | B7/B14 | Cw7/Cw8 | 290 | 24 | 370 | 37 |
Median (range) | 476 (230–990) | 23.4 (16–37) | 549 (280–1120) | 25.9 (17–38) | |||